Nutriband (NTRB) Projected to Post Earnings on Friday

Nutriband (NASDAQ:NTRBGet Free Report) is expected to announce its earnings results before the market opens on Friday, May 30th. Analysts expect the company to announce earnings of ($0.13) per share and revenue of $0.71 million for the quarter.

Nutriband (NASDAQ:NTRBGet Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.06). Nutriband had a negative net margin of 338.51% and a negative return on equity of 54.49%. The company had revenue of $0.64 million during the quarter, compared to the consensus estimate of $0.71 million. On average, analysts expect Nutriband to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nutriband Stock Performance

Shares of NTRB stock opened at $5.73 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.83 and a current ratio of 4.96. Nutriband has a fifty-two week low of $3.72 and a fifty-two week high of $11.78. The stock has a 50 day moving average price of $5.71 and a two-hundred day moving average price of $5.66. The company has a market capitalization of $63.91 million, a P/E ratio of -8.07 and a beta of 1.18.

Nutriband Company Profile

(Get Free Report)

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.

Featured Stories

Earnings History for Nutriband (NASDAQ:NTRB)

Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.